The last few months have seen a flurry of activity on Capitol Hill regarding prescription drug reform, with a particular focus on pharmacy benefit managers, or PBMs.
The U.S. Senate Finance Committee is set to markup a bipartisan PBM reform bill within the next few days.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
PBM Industry Shadowy, Congress Shines Much Needed Light
Sally C. Pipes
The last few months have seen a flurry of activity on Capitol Hill regarding prescription drug reform, with a particular focus on pharmacy benefit managers, or PBMs.
The U.S. Senate Finance Committee is set to markup a bipartisan PBM reform bill within the next few days.
The House Energy and Commerce Committee and the House Committee on Education and the Workforce are weighing PBM reform legislation of their own.
All these efforts have an eye on reducing drug costs for patients.
Click to read the full article in Newsmax.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.